1. Academic Validation
  2. Estimation of impurity profiles of drugs and related materials Part 18. Impurities and degradation products of mazipredone

Estimation of impurity profiles of drugs and related materials Part 18. Impurities and degradation products of mazipredone

  • J Pharm Biomed Anal. 1998 Sep 1;17(6-7):1029-36. doi: 10.1016/s0731-7085(98)00068-5.
M Gazdag 1 M Babják J Brlik S Mahó Z Tuba S Görög
Affiliations

Affiliation

  • 1 Chemical Works of Gedeon Richter Ltd., Budapest, Hungary.
Abstract

Reversed-phase HPLC methods using C-18 and C-8 columns as well as various isocratic and gradient systems with aqueous ammonium acetate, methanol and acetonitrile are described for the separation of the impurities of mazipredone (11beta,17-dihydroxy-21-(4-methyl-1-piperazinyl)-pregna-1,4-diene- 3,20-dione hydrochloride). These methods were used also for the estimation of the hydrolytic and oxidative degradation pathways of mazipredone in 0.1 M hydrochloric acid and sodium hydroxide at 80 degrees C. With the aid of HPLC-(APCI)-MS and HPLC-diode-array UV techniques 15 impurities and degradation products have been identified.

Figures
Products